Antizol

Quick links to important sections

Antizol

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Antizol

Quick Facts

Property Description
Active ingredient Fomepizole (4-methylpyrazole)
Form Sterile Liquid Formulation for Injection
Pharmacological class Antidote, Alcohol Dehydrogenase (ADH) Inhibitor
Common use Treatment of methanol and ethylene glycol poisoning
Origin Synthetic

What is Antizol (Fomepizole)? The Antidote Classification

Antizol is the trade name for the active pharmaceutical ingredient Fomepizole, a drug classified as a specific antidote used in acute toxicological emergencies. Fomepizole belongs to the pharmacological class of Alcohol Dehydrogenase (ADH) Inhibitors. Its specialized designation is clinically recognized for providing life-saving intervention in critical poisoning cases, a scenario where immediate action is paramount. The primary purpose of this medicine is to counteract the dangerous effects resulting from the ingestion of toxic alcohols, specifically ethylene glycol and methanol, providing critical intervention that stabilizes a patient during a poisoning crisis.

Composition, Origin, and Form of the Medicine

The drug Fomepizole is a synthetic, single-ingredient product derived from the pyrazole chemical family, prepared as a highly concentrated Sterile Liquid Formulation for Injection. The drug's composition consists of the active ingredient, Fomepizole, dissolved in an aqueous solution with necessary stabilizing excipients. This formulation is administered exclusively via the Intravenous (IV) Administration route, a feature distinguishing it from standard oral therapies. This route is essential in emergencies to ensure the drug achieves immediate and complete systemic availability, thus bypassing the variable absorption of an oral form.

How Fomepizole Works at a Foundational Level

Fomepizole functions fundamentally by a process of competitive inhibition, which means the drug binds to and effectively blocks the Alcohol Dehydrogenase enzyme. By occupying the ADH enzyme's active site, Fomepizole stops the body's natural processes from creating highly corrosive and cell-damaging toxic metabolites. This action provides a crucial therapeutic advantage over older, less precise methods. The clinical benefit is the immediate cessation of poisoning progression, allowing the relatively less-toxic parent substances to be safely cleared from the body, consequently preserving the function of vital organs such as the kidneys and central nervous system.

Regulatory References

  1. FOMEPIZOLE injection, solution - NIH DailyMed

What side effects are possible with Antizol?

Possible Side Effects and Safety Information

The safety profile of Antizol (fomepizole) is established through official regulatory documentation, which classifies potential adverse reactions by frequency and the body system affected.

Adverse Reaction Scope

Classification Common Reactions (Reported in 1% to 10% of users) System-Organ Classes Involved
Frequency Headache, Nausea, Vomiting, Dizziness, Increased Drowsiness, Bad/Metallic Taste, Injection Site Reactions, Lightheadedness, Paresthesia, Anxiety, Visual Disturbances, Bradycardia, Tachycardia, and Hypotension. Nervous System, Gastrointestinal, Cardiac, Vascular, General Disorders.
Serious Serious adverse reactions that are officially documented include severe allergic reactions (hypersensitivity) and the potential for a worsening of the underlying metabolic acidosis during the course of treatment.

Safety Considerations and Restrictions

  • Hypersensitivity Restriction: Antizol is restricted for use in individuals with a known serious hypersensitivity reaction to fomepizole or other pyrazoles.
  • Administration Safety: Reactions at the site of intravenous injection, such as inflammation (Phlebitis), are documented safety concerns related to the route of administration.
  • Population Notes: Regulatory labels include specific safety information for certain groups. For pediatric patients, the reported adverse event profile is generally consistent with that observed in adults. In patients with renal or hepatic impairment, official documents note the potential for altered drug clearance.

The overall safety profile is characterized by effects that are often mild to moderate and related to the drug's administration and central nervous system effects. The regulatory structure ensures that both frequent and clinically significant serious events are officially cataloged for comprehensive risk management.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documentation describes the signs and required actions associated with an overdosage of Antizol (Fomepizole), focusing strictly on observed clinical findings and mandated emergency response. An overdose is primarily characterized by central nervous system (CNS) effects and potential physiological changes.


Documented Overdose Manifestations

System Affected Clinical Manifestations (Officially Documented)
Central Nervous System Somnolence (lethargy), Dizziness, Headache, Vertigo, Unconsciousness (Coma), Seizures
Cardiovascular/Other Mild Sinus Bradycardia (slowed heart rate), Nausea, Vomiting, Transient Elevated Hepatic Transaminases

Required Emergency Actions

Upon any suspicion of Fomepizole overdosage, official labeling mandates that individuals seek immediate medical attention or contact emergency medical services. Urgent medical evaluation and treatment is required.

Management of Fomepizole overdosage is based on symptomatic and supportive treatment, including the continuous monitoring of vital signs and laboratory markers like hepatic transaminases. The regulatory documents confirm that no specific antidote is known for Fomepizole overdose. For severe cases, procedural interventions like haemodialysis are described as a method for drug removal.

Therapeutic Uses of Antizol

What Antizol Treats: Main Uses and Benefits

Antizol (Fomepizole) is a therapeutic intervention for confirmed or highly suspected poisoning caused by ethylene glycol or methanol, which are conditions associated with acute or disruptive episodes. Its use is commonly applied in settings marked by temporary physiological imbalance caused by these substances.

This medication is specifically used for managing the conditions that create noticeable physiological strain and symptoms related to systemic imbalance, namely methanol poisoning and ethylene glycol poisoning. Its application is relevant across the affected population, including adults and pediatric patients, providing support that helps ease the overall symptom burden.

Quick Fact: Therapeutic Focus

Therapeutic Focus Benefit to Patient
Toxic Alcohol Poisoning Supports the body in managing the threat to functional stability across key systems.

This intervention may assist with maintaining functional stability and is relevant for easing the symptoms that interfere with daily functioning. The therapy offers symptomatic relief that helps patients cope more steadily with difficult episodes.

Regulatory References

  1. Australian Therapeutic Goods Administration (TGA) Public Assessment Report

Eligibility and Restrictions for Use

Antizol (fomepizole) is primarily administered in a hospital setting to treat methanol and ethylene glycol poisoning. Its use is highly specific and guided by a medical professional based on clinical presentation and laboratory evidence of poisoning.


Who Can Use Antizol?

The primary patient population includes individuals diagnosed with:

  • Suspected or confirmed methanol poisoning (e.g., from drinking contaminated or industrial alcohols).
  • Suspected or confirmed ethylene glycol poisoning (e.g., from ingesting antifreeze).
  • It is often used as an alternative to ethanol therapy in these specific types of poisoning.

Who Cannot Use Antizol?

While few absolute contraindications exist for a life-saving antidote, the following considerations are important:

Category Specific Considerations
Hypersensitivity Individuals with a known, severe allergy or hypersensitivity reaction to fomepizole or any of its components.
Non-Toxic Exposure It is not indicated for general alcohol intoxication (ethanol) or poisoning by substances other than methanol or ethylene glycol.
Pregnancy/Breastfeeding Use during pregnancy and breastfeeding requires careful consideration, as the potential benefit must clearly outweigh the potential risk to the fetus or infant.

Fomepizole must always be administered under the close supervision of qualified healthcare professionals.

What should I know about interactions with other medicines?

Interaction Map: Interactions with other medicines and products — official regulatory information for Antizol

Interaction Scope

Category Official Regulatory Documentation Summary
Medicinal product categories with documented interactions Agents that induce or inhibit the Cytochrome P450 (CYP) system.
Specific interacting medicines (if explicitly listed) Ethanol (Alcohol) (Classified as a substance/product interaction).
Mechanistic basis of interactions (only if stated in label) Competitive inhibition of Alcohol Dehydrogenase (ADH), resulting in reciprocal pharmacokinetic interaction. The drug also demonstrates auto-induction of its own metabolism via the CYP system.
Timing-based interaction rules (if applicable) Mandatory restriction against concurrent administration with Ethanol.
Population-specific interaction notes (if applicable) No specific population-dependent interaction severity is officially documented in regulatory labels.
Interaction-related restrictions Co-administration with Ethanol is classified as a contraindicated combination. Procedurally, the product must not be mixed with preparations or devices containing polycarbonate materials.

Interaction Classifications (High-Level)

Classification Regulatory Status / Context
Interaction severity classification (as defined in official documents) Contraindicated/Not Recommended (for Ethanol); Potential Reciprocal Interaction (for CYP Inhibitors/Inducers).
Regulatory basis FDA and EMA-aligned national agency labeling.
Interaction-context constraints (as defined in official documents) Reciprocal interactions involving CYP enzyme modulation are noted in official labeling as unstudied.

Resulting Interaction Structure

Official interaction statements:

  • Co-administration with Ethanol is a contraindicated combination due to a reciprocal pharmacokinetic interaction.
  • This interaction significantly increases the systemic exposure of both Antizol and Ethanol by mutually reducing their elimination rates through the ADH pathway.
  • Antizol causes auto-induction of its own metabolism via the CYP system, which accelerates its elimination rate during prolonged therapy.
  • Potential reciprocal interactions with medicinal products that increase or inhibit the CYP system are noted in regulatory labels.
  • The drug must not be prepared or administered using devices containing polycarbonate materials due to physical incompatibility.

Connection to the overall interaction profile:

The regulatory profile for Fomepizole is strictly defined by a mandatory restriction against the concurrent use of Ethanol, which stems from a confirmed and mutual reduction in the elimination of both substances. This framework also includes official statements cautioning about potential reciprocal interactions with agents that modulate the hepatic CYP enzyme system, based on the drug's known metabolic self-induction. These documented interaction patterns establish critical administration limits.

Mechanism of Action

Competitive Inhibition of Alcohol Dehydrogenase

Antizol (Fomepizole) functions as a highly specific competitive inhibitor of the enzyme Alcohol Dehydrogenase (ADH), which is predominantly located in the liver. Its molecular structure allows it to bind to the ADH active site with an affinity that is thousands of times greater than the toxic alcohol substrates, effectively blocking the enzyme's capacity to initiate the metabolic process.


Halting the Toxic Metabolic Cascade

This molecular action immediately halts the metabolic pathway that converts parent toxic alcohols (methanol and ethylene glycol) into highly corrosive metabolites, such as formic acid and glycolate. By restricting the continuous creation of these damaging byproducts, the mechanism limits further changes to systemic pH and restricts the accumulation of toxic compounds, curtailing the biochemical progression.


Maintenance of Critical Tissue Integrity

The physiological consequence of the enzyme blockade is the maintenance of critical tissue integrity. The unmetabolized parent alcohols, which do not undergo the toxic metabolic step, are subsequently cleared from the body primarily through renal excretion. This mechanism reduces the occurrence of metabolite-induced toxicity in the kidneys, central nervous system, and retina.

Dosage and Administration Information

Fomepizole is administered exclusively via intravenous (IV) infusion in a hospital setting. The medicine is supplied as a sterile liquid concentrate and must be diluted in a minimum of 100 mL of 0.9% sodium chloride or 5% dextrose solution before use. The diluted solution must then be infused slowly over a period of 30 minutes; it is not to be given as a rapid injection. If the contents of the vial appear solid, official instructions require the vial to be warmed to liquefy the contents prior to dilution.

The administration follows a defined, weight-based dosing protocol. Treatment begins with an initial loading dose of 15 mg/kg body weight. This is followed by maintenance doses of 10 mg/kg every 12 hours for the first four doses. Following this, the maintenance dose is officially increased to 15 mg/kg every 12 hours to compensate for changes in how the body processes the drug.

The dosing schedule is highly dependent on other concurrent procedures. When a patient is receiving hemodialysis, the maintenance dose frequency must be increased to every 4 hours due to the drug's removal by the dialysis procedure. The entire treatment course is not based on a fixed time period but is continued until the toxic alcohol concentrations in the blood are verified to be below 20 mg/dL and the patient exhibits a normal arterial blood pH. Dosing for older adults requires caution due to potential changes in kidney function.

Recent Clinical Evidence

Recent Clinical Evidence

The clinical evidence for Antizol (fomepizole) is primarily centered on its use as an antidote for poisoning with ethylene glycol (e.g., antifreeze) and methanol (e.g., windshield washer fluid and solvents).

Core Efficacy Findings

Studies, including controlled clinical trials and observational data, have shown that fomepizole is associated with the blockade of the enzyme alcohol dehydrogenase (ADH). This action is studied to prevent the metabolism of ethylene glycol and methanol into their highly toxic byproducts (such as formic acid and oxalic acid), which are responsible for metabolic acidosis, acute renal failure, and visual disturbances.

  • Initial Trials: Key studies demonstrated that in patients receiving fomepizole, the plasma concentrations of toxic metabolites of ethylene glycol and methanol did not rise during the initial phases of treatment.
  • Treatment Endpoints: Treatment in clinical settings is guided by frequent laboratory measurements. Studies evaluate the sustained presence of the compound until the patient is asymptomatic and the methanol or ethylene glycol concentrations fall below a target level (typically 20 mg/dL).

Emerging Research and Safety Profile

While the primary established use of Antizol is for ethylene glycol and methanol toxicity, research continues to investigate its potential in other settings.

  • Combination Therapy: Some contemporary clinical trials are evaluating the effect of Antizol as an investigational adjunct treatment alongside N-acetylcysteine (NAC) for certain high-risk cases of acetaminophen (paracetamol) poisoning. This research is currently exploring whether the combination can affect markers of liver injury. This use remains investigational and off-label.
  • Adverse Event Profile: Across clinical trials and use, Antizol is generally associated with minor adverse effects. The most frequently reported events observed in patients include headache, nausea, and dizziness/drowsiness.

Key Studies & References

  1. WHO Model List of Essential Medicines: Fomepizole Monograph

Frequently Asked Questions (FAQ)

Common questions about Antizol (FAQ)


Q: Is Antizol the same as other treatments I have heard of?

Antizol is a specific antidote used to treat methanol or ethylene glycol poisoning. Official documents state that it can be used as an alternative to ethanol (alcohol) therapy. For safety reasons, the concurrent use of Antizol with ethanol is generally restricted.

Q: How quickly does Antizol start working?

Antizol is administered by a slow intravenous (IV) infusion over 30 minutes to ensure immediate systemic availability. The drug is designed to rapidly bind to the target enzyme, immediately halting the metabolic process that creates toxic byproducts.

Q: What is the typical time frame for Antizol's effect?

Antizol treatment is highly personalized and is not based on a set time frame. Treatment is continued until laboratory tests verify that the levels of the toxic alcohol in the blood are below a specific target, and the patient’s acid-base balance is confirmed to be normal. The continuation of treatment is guided by careful and frequent monitoring by the healthcare team.

Q: Are the reported side effects usually temporary?

The most frequently reported adverse effects of Antizol, such as headache, dizziness, and drowsiness, are generally described as mild to moderate. Official guidance related to driving suggests that these effects may be present for a few days following administration.

Q: How does Antizol interact with medications for heart conditions?

Official regulatory information warns of potential reciprocal interactions with medicines that modulate the body’s Cytochrome P450 (CYP) enzyme system, which is involved in drug processing. Since specific studies on common heart medications have not been documented, a definitive interaction profile for these drugs is not defined in the regulatory labels.

Q: Is Antizol safe for people with kidney problems?

Antizol's byproducts are primarily cleared through the kidneys. Official documents state that definitive studies to assess the drug’s processing in patients with renal (kidney) impairment have not been completed. For this reason, patients with known kidney problems are typically managed with careful monitoring during treatment.

Q: What if a patient has pre-existing liver issues? Can they still use Antizol?

Since Antizol is processed through the liver, official guidance specifies that careful monitoring of the patient's liver enzymes (hepatic transaminases) is part of the management if pre-existing liver impairment is a concern. Definitive processing studies have not been performed in patients with liver disease.

Q: What do official sources say about the long-term effects of Antizol?

Antizol is used as an antidote for acute, immediate poisoning, and regulatory focus is centered on its immediate effects and short-term safety profile. Regulatory information does not contain specific data on the long-term effects of the drug following this acute administration.

Q: How do doctors monitor the effects of Antizol?

During treatment, doctors closely monitor the patient’s vital signs and frequently perform laboratory tests. They measure the concentrations of the toxic alcohol in the blood to track the poisoning. They also monitor blood gases, liver enzymes, and blood cell counts, as transient changes in these values have been noted with repeated dosing.

Q: What are the restrictions on using Antizol during pregnancy?

Antizol should only be given to a pregnant patient if the potential therapeutic benefit is determined to clearly outweigh any potential risk to the fetus. Official regulatory information states that it is not known whether the drug can cause fetal harm.

Q: Is it normal to feel a change right after Antizol is given?

Reported adverse events associated with Antizol include subjective feelings such as lightheadedness, dizziness, and a metallic taste in the mouth. Additionally, pain or inflammation at the injection site is a documented safety concern related to the method of intravenous administration.

Q: Do any specific food items interact with Antizol?

Official interaction guidance focuses on medicinal products and ethanol. Specific interactions between Antizol and common food items or products other than alcohol are not explicitly documented in the core regulatory labels.

Q: Can Antizol be taken with common over-the-counter pain relievers?

Regulatory documents state that potential reciprocal interactions may occur with drugs that affect the body's CYP enzyme system. However, specific studies on common non-prescription pain relievers have not been performed, and these medicines are not explicitly listed in general interaction statements.

Q: Are there certain supplements that should be avoided while using Antizol?

Official guidance warns of possible interactions with products, including supplements, that can either increase or inhibit the CYP enzyme system in the body. A potential interaction is noted as possible if a supplement is known to affect the CYP enzyme system.

Q: Does Antizol interact with herbal remedies?

Official regulatory labels state that potential reciprocal interactions may occur with products, including herbal remedies, that affect the body's CYP enzyme system. A potential interaction is noted as possible if an herbal product modulates the CYP enzyme system, but specific remedies are not explicitly named.

Q: Is Antizol ever used in children?

Yes, Antizol is used in pediatric patients for the treatment of methanol and ethylene glycol poisoning. Official regulatory documents provide dosing protocols for children, although some documents note that safety and effectiveness have not been definitively established in all pediatric groups.

Q: What is the difference between Antizol and supportive care?

Antizol is defined as a specific antidote that directly stops the production of toxic metabolites in the body. Supportive care refers to other necessary medical treatments used simultaneously with the antidote to address the bodily damage already caused by the poisoning, such as correcting the body's acid levels.

Q: Is Antizol part of a standard treatment protocol?

Yes, Antizol is considered a primary treatment choice for confirmed or suspected methanol and ethylene glycol poisoning. Its use is guided by clinical evidence and frequent laboratory measurements as part of a structured, recognized treatment approach.

Q: Does Antizol interact with common medications for anxiety or sleep?

Official guidance notes potential interactions with drugs that affect the CYP enzyme system. The known Central Nervous System (CNS) effects, such as drowsiness, suggest a potential for interaction with other CNS depressant medications.

Q: How do scientists describe the chemical structure of Antizol?

The active ingredient in Antizol, fomepizole, is a synthetic substance. Official descriptions classify it as a pyrazole compound, specifically 4-methylpyrazole.

Q: What is the role of Antizol in the body once it is administered?

Antizol’s primary role is to competitively block the Alcohol Dehydrogenase enzyme in the liver. This action prevents the breakdown of toxic alcohols into corrosive metabolites, allowing the less-toxic parent alcohols to be safely eliminated from the body, mostly through the kidneys.

Q: Do doctors consider Antizol to be a 'high-risk' medication?

Antizol is classified as an antidote for acute, life-threatening poisoning, and its use requires immediate administration and continuous, close monitoring in a hospital setting.

Q: What happens if a dose of Antizol is delayed?

Official dosing protocols emphasize the importance of timely administration, especially when a patient is receiving hemodialysis. Deviations from the schedule are managed by the healthcare team based on these critical lab results.

Q: How does Antizol affect blood pressure?

Official documentation reports that adverse reactions associated with Antizol can include effects on blood pressure. Both a potential decrease in blood pressure (hypotension) and, less frequently, an increase in blood pressure (hypertension) have been documented.

Q: Is Antizol associated with allergic reactions?

Yes, official safety information documents that Antizol is associated with allergic reactions. Serious hypersensitivity (allergic) reactions have been reported, which is why it is restricted for use in patients with a known serious allergy to Antizol or other similar pyrazole medicines.

Q: Does Antizol affect mental clarity or mood?

Official adverse event reports include effects on the central nervous system such as increased drowsiness, dizziness, and anxiety. Patients have also reported feelings of lightheadedness or decreased environmental awareness following administration.

Q: Can Antizol be administered more than once?

Yes, the full treatment course for Antizol includes an initial dose followed by multiple maintenance doses administered at defined intervals. This schedule continues until laboratory confirmation indicates that the toxic alcohol levels are safe and the patient’s clinical status is normalized.

How should Antizol be stored and disposed of?

The storage and handling of Antizol (fomepizole) are strictly defined by regulatory requirements to ensure product integrity.

Vial Storage and Handling

  • Storage Temperature: Store the undiluted vials at controlled room temperature, 20 to 25 C (68 to 77 F). The product may solidify if stored at temperatures below 25 C.
  • Handling Solidification: If solidification occurs, the drug's quality is not affected. The solid must be liquefied by running the vial under warm water or holding it in the hand before use.
  • Protection: Keep the drug in the original container, protected from light.
  • Compatibility: Do not use polycarbonate syringes or needles for dilution or administration, as the drug can interact with the material.

Stability and Disposal

  • Diluted Solution Stability: Once diluted in 0.9% Sodium Chloride or Dextrose 5% Injection, the solution is stable for 24 hours at room temperature or under refrigeration.
  • Disposal: Any unused product or waste material must be disposed of according to local regulations for infectious waste and institutional operating procedures.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Antizol found in:

A-Z Index: